| Autor: |
Laffita-Mesa, José, Bauer, Peter, Kourí, Vivian, Peña Serrano, Leodani, Roskams, Jane, Almaguer Gotay, Dennis, Montes Brown, Julio, Martínez Rodríguez, Pedro, González-Zaldívar, Yanetza, Almaguer Mederos, Luís, Cuello-Almarales, Dany, Aguiar Santiago, Jorge |
| Předmět: |
|
| Zdroj: |
Human Genetics; Apr2012, Vol. 131 Issue 4, p625-638, 14p, 2 Diagrams, 2 Charts, 4 Graphs |
| Abstrakt: |
Pathogenic CAG (cytosine-adenine-guanine) expansions beyond certain thresholds in the ataxin-2 (ATXN2) gene cause spinocerebellar ataxia type 2 (SCA2) and were shown to contribute to Parkinson disease, amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Regulation of ATXN2 gene expression and the function of the protein product are not known. SCA2 exhibits an inverse correlation between the size of the CAG repeat and the age at disease onset. However, a wide range of age at onset are typically observed, with CAG repeat number alone explaining only partly this variability. In this study, we explored the hypothesis that ATXN2 levels could be controlled by DNA methylation and that the derangement of this control may lead to escalation of disease severity and influencing the age at onset. We found that CpG methylation in human ATXN2 gene promoter is associated with pathogenic CAG expansions in SCA2 patients. Different levels of methylation in a SCA2 pedigree without an intergenerational CAG repeat instability caused the disease anticipation in a SCA2 family. DNA methylation also influenced the disease onset in SCA2 homozygotes and SCA3 patients. In conclusion, our study points to a novel regulatory mechanism of ATXN2 expression involving an epigenetic event resulting in differential disease course in SCA2 patients. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Full text from SpringerLink